Finance

Lists
ORX:STO
Orexo AB
5,11 SEK
-1,92%
(-0,100) 1D
26-окт., 17:29:37 GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ORX...
Open
5,01 SEK
High
5,19 SEK
Low
4,90 SEK
Mkt. cap
179,50 млн
Avg. vol.
123,54 миң
Volume
41,78 миң
P/E ratio
0,22
52-wk high
36,00 SEK
52-wk low
4,90 SEK
EPS
23,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
5,01 SEK
High
5,19 SEK
Low
4,90 SEK
Mkt. cap
179,50 млн
Avg. vol.
123,54 миң
Volume
41,78 миң
P/E ratio
0,22
52-wk high
36,00 SEK
52-wk low
4,90 SEK
EPS
23,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorPharmaceutical industry
Websiteorexo.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
3,30 млн
5,00 млн
3,50 млн
800,00 миң
Cost of goods sold
2,60 млн
500,00 миң
100,00 миң
100,00 миң
Cost of revenue
2,60 млн
500,00 миң
100,00 миң
100,00 миң
Research and development expenses
55,60 млн
50,10 млн
53,40 млн
54,10 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28,00 млн
37,40 млн
58,20 млн
15,90 млн
Operating expense
80,70 млн
80,20 млн
106,50 млн
62,20 млн
Total operating expenses
83,30 млн
80,70 млн
106,60 млн
62,30 млн
Operating income
-80,00 млн
-75,70 млн
-103,10 млн
-61,50 млн
Other non operating income
-200,00 миң
-100,00 миң
-300,00 миң
100,00 миң
EBT including unusual items
-115,50 млн
-104,20 млн
-102,30 млн
-95,80 млн
EBT excluding unusual items
-93,50 млн
-104,50 млн
-103,00 млн
-61,20 млн
Income tax expense
100,00 миң
1,00 млн
200,00 миң
22,10 млн
Effective tax rate
-0,09%
-0,96%
-0,20%
-23,07%
Other operating expenses
-2,90 млн
-7,30 млн
-5,10 млн
-7,80 млн
Net income
724,80 млн
-133,90 млн
-100,40 млн
-96,40 млн
Net profit margin
21 963,64%
-2 678,00%
-2 868,57%
-12 050,00%
Earnings per share
-
-
-2,53
-
Interest and investment income
600,00 миң
4,40 млн
2,00 млн
1,30 млн
Interest expense
-12,20 млн
-32,90 млн
-
-
Net interest expenses
-11,60 млн
-28,50 млн
2,00 млн
1,30 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-46,80 млн
-66,90 млн
-94,90 млн
-53,40 млн
Gain or loss from assets sale
-
-
-
300,00 миң
AI content may include mistakes. Learn more
Google колдонмолору